+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Metagenomics Market Size, Share & Trends Analysis Report By Technology (Shotgun Sequencing, 16S Sequencing, Whole Genome Sequencing), By Product, By Workflow, By Application, By Region, And Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 180 Pages
  • June 2023
  • Region: Global
  • Grand View Research
  • ID: 4661535
Description Jump to:
The global metagenomics market size is expected to reach USD 4.02 billion by 2030, according to this report. The market is expected to expand at a CAGR of 14.8% from 2023 to 2030. The increasing research in genomics and proteomics, the rising adoption of personalized medicines, and escalating requirement for biologic products are driving the demand for sequencing, fueling the growth of the industry. For instance, in August 2022, Illumina, Inc. announced its plans to expand genomics operations in Brazil by developing a solution center. The establishment of the new facility is the result of rising demand for clinical genomics and accelerating the company's footprint in Latin America.

A boost in R&D investments by the players is estimated to have a considerable impact on the usage of metagenomics in numerous applications. For instance, in April 2021, Agilent Technologies, Inc. acquired Resolution Bioscience, Inc., an NGS-based precision oncology solution developing company. The combination of Resolution Bioscience's noninvasive liquid biopsy platform with Agilent's tissue-based companion diagnostics is anticipated to expand Agilent's market position in NGS technologies for precision oncology.

Another factor contributing to the high adoption of metagenomics for environmental use is the direct involvement of microorganisms in the biogeochemical cycle. The degradation of carbon sources such as petroleum hydrocarbons by microbes has encouraged researchers to study metagenomics processes for the production of biofuels. In addition, the presence of a large number of undiscovered biomolecules in non-cultured microorganisms accelerated the adoption of metagenomics in agriculture, food safety, chemical, industrial, and other related applications.

Since the outbreak of COVID-19, key stakeholders in the life sciences and biotechnology industry are seeking solutions for COVID-19 tracking, detection, and treatment. Metagenomics analysis plays a crucial role in the detection and tracing of the virus. Various sequencing surveillance platforms and solutions are being deployed for effective diagnosis of infection. For instance, in May 2021, Oxford University and Oracle announced a strategic partnership to develop robust cloud-based genomic sequencing and analysis platform to mitigate the risk of coronavirus infection.

Moreover, funds provided by the government for promoting research in academic institutes, which use NGS platforms, further increase the usage of metagenomics tools. For instance, in February 2021, the Canadian government invested USD 53 million to implement a multilayered approach for the diagnosis of COVID-19. The Canadian government will utilize genome sequencing and analysis technologies to achieve desired outcomes.

The quality of data generated through metagenomics is another factor that increases the cost of analysis. The quality of data is highly dependent on the average number of times the bases are run during the sequencing process. The high-quality analysis is expensive. However, the adoption of emerging novel techniques, such as RNA-Seq, is rapidly increasing owing to accuracy and rapid results along with a decline in prices. It is observed that the cost of sequencing falls 5 to 10 times every year and the value of computing power doubles every two years.

Metagenomics Market Report Highlights

  • By product, the kits & reagents segment accounts for the largest market share. The demand in terms of volumes is high for these products. High market penetration of kits and reagents further contributes toward their highest revenue share
  • By technology, the shotgun sequencing segment is estimated to have the largest share with the fastest CAGR over the forecast period. The advantages such as the ability to read all genomic DNA in a sample give a competitive edge to the technology resulting in the growing adoption of shotgun sequencing among researchers
  • By application, the clinical diagnostics segment is anticipated to have the fastest CAGR throughout the forecast period. Owing to the research initiatives for the development of personalized therapies using sequencing technology are expected to impact growth in the area of clinical research, hence, propelling the growth
  • By workflow, the sequencing segment held the largest share in 2022, owing to the adoption of easy workflow models, demand for rapid results, and lower cost of per sample analysis compared to the price of systems driving the demand for sequencing & data analytics services
  • North America dominated the global metagenomics industry in 2022 owing to the presence of well-established marketing and distribution network of major companies and large-sized research & academic institutes, which focus on genomic studies
  • A few of the key players include Illumina. Inc.; Thermo Fisher Scientific, Inc.; QIAGEN; and Promega Corporation


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Information analysis
1.2.2. Market formulation & data visualization
1.2.3. Data validation & publishing
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Declining expenses of sequencing
3.3.2. Developments in biotechnology & bioinformatics techniques
3.3.3. Rising interest in microbial screening for different investigations
3.3.4. Emergence of new fields in genomics that complement metagenomics
3.4. Market Restraint Analysis
3.4.1. Limited accessibility to computation and different analytic tools
3.4.2. High overall cost of metagenomics
3.5. Business Environment Analysis
3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.5.2. Porter’s Five Forces Analysis
3.6. COVID - 19 Impact Analysis
Chapter 4. Technology Business Analysis
4.1. Metagenomics market: Technology Movement Analysis
4.2. Shotgun Sequencing
4.2.1. Shotgun Sequencing Market, 2018 - 2030 (USD Million)
4.3. 16S Sequencing
4.3.1. 16S Sequencing Market, 2018 - 2030 (USD Million)
4.4. Whole Genome Sequencing
4.4.1. Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
4.5. Others
4.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Product Business Analysis
5.1. Metagenomics market: Product Movement Analysis
5.2. Kits and Reagents
5.2.1. Kits and Reagents Market, 2018 - 2030 (USD Million)
5.3. Sequencing & Data Analytics Services
5.3.1. Sequencing & Data Analytics Services Market, 2018 - 2030 (USD Million)
5.4. Software
5.4.1. Software Market, 2018 - 2030 (USD Million)
Chapter 6. Application Business Analysis
6.1. Metagenomics market: Application Movement Analysis
6.2. Environmental Application
6.2.1. Environmental Application Market, 2018 - 2030 (USD Million)
6.3. Clinical Diagnostics Applications
6.3.1. Clinical Diagnostics Applications Market, 2018 - 2030 (USD Million)
6.4. Drug Discovery Applications
6.4.1. Drug Discovery Applications Market, 2018 - 2030 (USD Million)
6.5. Biotechnology Applications
6.5.1. Biotechnology Applications Market, 2018 - 2030 (USD Million)
6.6. Food & Nutrition Applications
6.6.1. Food & Nutrition Applications Market, 2018 - 2030 (USD Million)
6.7. Others
6.7.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Workflow Business Analysis
7.1. Metagenomics market: Workflow Movement Analysis
7.2. Pre - sequencing
7.2.1. Pre - sequencing Market, 2018 - 2030 (USD Million)
7.3. Sequencing
7.3.1. Sequencing Market, 2018 - 2030 (USD Million)
7.4. Data Analysis
7.4.1. Data Analysis Market, 2018 - 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Metagenomics market Share By Region, 2022 & 2030
8.2. North America
8.2.1. SWOT Analysis
8.2.2. North America Metagenomics market, 2018 - 2030 (USD Million)
8.2.3. U.S.
8.2.3.1. Key Country Dynamics
8.2.3.2. Competitive Scenario
8.2.3.3. Regulatory Framework
8.2.3.4. Target Disease Prevalence
8.2.3.5. U.S. Metagenomics market, 2018 - 2030 (USD Million)
8.2.4. Canada
8.2.4.1. Key Country Dynamics
8.2.4.2. Competitive Scenario
8.2.4.3. Regulatory Framework
8.2.4.4. Target Disease Prevalence
8.2.4.5. Canada Metagenomics market, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. SWOT Analysis
8.3.2. Europe Metagenomics market, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. Target Disease Prevalence
8.3.3.5. Germany Metagenomics market, 2018 - 2030 (USD Million)
8.3.4. UK
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. Target Disease Prevalence
8.3.4.5. UK Metagenomics market, 2018 - 2030 (USD Million)
8.3.5. France
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Regulatory Framework
8.3.5.4. Target Disease Prevalence
8.3.5.5. France Metagenomics market, 2018 - 2030 (USD Million)
8.3.6. Italy
8.3.6.1. Key Country Dynamics
8.3.6.2. Competitive Scenario
8.3.6.3. Regulatory Framework
8.3.6.4. Target Disease Prevalence
8.3.6.5. Italy Metagenomics market, 2018 - 2030 (USD Million)
8.3.7. Spain
8.3.7.1. Key Country Dynamics
8.3.7.2. Competitive Scenario
8.3.7.3. Regulatory Framework
8.3.7.4. Target Disease Prevalence
8.3.7.5. Spain Metagenomics market, 2018 - 2030 (USD Million)
8.3.8. Denmark
8.3.8.1. Key Country Dynamics
8.3.8.2. Competitive Scenario
8.3.8.3. Regulatory Framework
8.3.8.4. Target Disease Prevalence
8.3.8.5. Denmark Metagenomics market, 2018 - 2030 (USD Million)
8.3.9. Sweden
8.3.9.1. Key Country Dynamics
8.3.9.2. Competitive Scenario
8.3.9.3. Regulatory Framework
8.3.9.4. Target Disease Prevalence
8.3.9.5. Sweden Metagenomics market, 2018 - 2030 (USD Million)
8.3.10. Norway
8.3.10.1. Key Country Dynamics
8.3.10.2. Competitive Scenario
8.3.10.3. Regulatory Framework
8.3.10.4. Target Disease Prevalence
8.3.10.5. Norway Metagenomics market, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. SWOT Analysis
8.4.2. Asia Pacific Metagenomics market, 2018 - 2030 (USD Million)
8.4.3. Japan
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Target Disease Prevalence
8.4.3.5. Japan Metagenomics market, 2018 - 2030 (USD Million)
8.4.4. China
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. Target Disease Prevalence
8.4.4.5. China Metagenomics market, 2018 - 2030 (USD Million)
8.4.5. India
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. Target Disease Prevalence
8.4.5.5. India Metagenomics market, 2018 - 2030 (USD Million)
8.4.6. South Korea
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Target Disease Prevalence
8.4.6.5. South Korea Metagenomics market, 2018 - 2030 (USD Million)
8.4.7. Australia
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. Target Disease Prevalence
8.4.7.5. Australia Metagenomics market, 2018 - 2030 (USD Million)
8.4.8. Thailand
8.4.8.1. Key Country Dynamics
8.4.8.2. Competitive Scenario
8.4.8.3. Regulatory Framework
8.4.8.4. Target Disease Prevalence
8.4.8.5. Thailand Metagenomics market, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. SWOT Analysis
8.5.2. Latin America Metagenomics market, 2018 - 2030 (USD Million)
8.5.3. Brazil
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Target Disease Prevalence
8.5.3.5. Brazil Metagenomics market, 2018 - 2030 (USD Million)
8.5.4. Mexico
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. Target Disease Prevalence
8.5.4.5. Mexico Metagenomics market, 2018 - 2030 (USD Million)
8.5.5. Argentina
8.5.5.1. Key Country Dynamics
8.5.5.2. Competitive Scenario
8.5.5.3. Regulatory Framework
8.5.5.4. Target Disease Prevalence
8.5.5.5. Argentina Metagenomics market, 2018 - 2030 (USD Million)
8.6. MEA
8.6.1. SWOT Analysis
8.6.2. MEA Metagenomics market, 2018 - 2030 (USD Million)
8.6.3. South Africa
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Target Disease Prevalence
8.6.3.5. South Africa Metagenomics market, 2018 - 2030 (USD Million)
8.6.4. Saudi Arabia
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. Target Disease Prevalence
8.6.4.5. Saudi Arabia Metagenomics market, 2018 - 2030 (USD Million)
8.6.5. UAE
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Target Disease Prevalence
8.6.5.5. UAE Metagenomics market, 2018 - 2030 (USD Million)
8.6.6. Kuwait
8.6.6.1. Key Country Dynamics
8.6.6.2. Competitive Scenario
8.6.6.3. Regulatory Framework
8.6.6.4. Target Disease Prevalence
8.6.6.5. Kuwait Metagenomics market, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Profiles/Listing
9.3.1. Illumina, Inc.
9.3.1.1. Overview
9.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.1.3. Product Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Thermo Fisher Scientific, Inc.
9.3.2.1. Overview
9.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.2.3. Product Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Bio - Rad Laboratories, Inc..
9.3.3.1. Overview
9.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.3.3. Product Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. PerkinElmer, Inc.
9.3.4.1. Overview
9.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.4.3. Product Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Promega Corporation
9.3.5.1. Overview
9.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.5.3. Product Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Oxford Nanopore Technologies
9.3.6.1. Overview
9.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.6.3. Product Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Qiagen
9.3.7.1. Overview
9.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.7.3. Product Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Takara Bio, Inc.
9.3.8.1. Overview
9.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.8.3. Product Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Novogene Co., Ltd.
9.3.9.1. Overview
9.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.9.3. Product Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. F. Hoffmann - La Roche Ltd.
9.3.10.1. Overview
9.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.10.3. Product Benchmarking
9.3.10.4. Strategic Initiatives
List of Tables
Table 1: List of Secondary Sources
Table 2: List of Abbreviations
Table 3: Global Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 4: Global Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 5: Global Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 6: Global Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 7: Global Metagenomics Market, by Region, 2018-2030 (USD Million)
Table 8: North America Metagenomics Market, by Country, 2018-2030 (USD Million)
Table 9: North America Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 10: North America Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 11: North America Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 12: North America Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 13: U.S. Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 14: U.S. Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 15: U.S. Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 16: U.S. Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 17: Canada Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 18: Canada Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 19: Canada Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 20: Canada Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 21: Europe Metagenomics Market, by Country, 2018-2030 (USD Million)
Table 22: Europe Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 23: Europe Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 24: Europe Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 25: Europe Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 26: Germany Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 27: Germany Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 28: Germany Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 29: Germany Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 30: UK Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 31: UK Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 32: UK Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 33: UK Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 34: France Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 35: France Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 36: France Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 37: France Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 38: Italy Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 39: Italy Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 40: Italy Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 41: Italy Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 42: Spain Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 43: Spain Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 44: Spain Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 45: Spain Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 46: Denmark Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 47: Denmark Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 48: Denmark Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 49: Denmark Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 50: Norway Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 51: Norway Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 52: Norway Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 53: Norway Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 54: Sweden Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 55: Sweden Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 56: Sweden Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 57: Sweden Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 58: Asia Pacific Metagenomics Market, by Country, 2018-2030 (USD Million)
Table 59: Asia Pacific Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 60: Asia Pacific Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 61: Asia Pacific Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 62: Asia Pacific Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 63: China Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 64: China Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 65: China Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 66: China Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 67: Japan Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 68: Japan Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 69: Japan Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 70: Japan Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 71: India Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 72: India Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 73: India Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 74: India Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 75: South Korea Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 76: South Korea Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 77: South Korea Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 78: South Korea Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 79: Australia Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 80: Australia Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 81: Australia Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 82: Australia Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 83: Latin America Metagenomics Market, by Country, 2018-2030 (USD Million)
Table 84: Thailand Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 85: Thailand Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 86: Thailand Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 87: Thailand Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 88: Latin America Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 89: Latin America Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 90: Latin America Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 91: Latin America Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 92: Brazil Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 93: Brazil Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 94: Brazil Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 95: Brazil Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 96: Mexico Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 97: Mexico Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 98: Mexico Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 99: Mexico Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 100: Argentina Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 101: Argentina Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 102: Argentina Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 103: Argentina Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 104: Middle East & Africa Metagenomics Market, by Country, 2018-2030 (USD Million)
Table 105: Middle East & Africa Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 106: Middle East & Africa Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 107: Middle East & Africa Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 108: Middle East & Africa Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 109: South Africa Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 110: South Africa Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 111: South Africa Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 112: South Africa Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 113: Saudi Arabia Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 114: Saudi Arabia Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 115: Saudi Arabia Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 116: Saudi Arabia Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 117: UAE Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 118: UAE Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 119: UAE Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 120: UAE Metagenomics Market, Workflow, 2018-2030 (USD Million)
Table 121: Kuwait Metagenomics Market, by Technology, 2018-2030 (USD Million)
Table 122: Kuwait Metagenomics Market, by Product, 2018-2030 (USD Million)
Table 123: Kuwait Metagenomics Market, by Application, 2018-2030 (USD Million)
Table 124: Kuwait Metagenomics Market, Workflow, 2018-2030 (USD Million)
List of Figures
Fig. 1: Market research process
Fig. 2: Information Procurement
Fig. 3: Primary Research Pattern
Fig. 4: Market Research Approaches
Fig. 5: Value Chain - Based Sizing & Forecasting
Fig. 6: Market Formulation & Validation
Fig. 7: Metagenomics, Market Segmentation
Fig. 8: Market Snapshot, 2021
Fig. 9: Market Trends & Outlook
Fig. 10: Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11: Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12: Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 13: SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14: Porter’s Five Forces Analysis
Fig. 15: Market Penetration Vs Growth Prospect Mapping, 2021
Fig. 16: Global Metagenomics Market: Technology Movement Analysis
Fig. 17: Global Metagenomics Market, for Shotgun Sequencing, 2018-2030 (USD Million)
Fig. 18: Global Metagenomics Market, for 16S Sequencing, 2018-2030 (USD Million)
Fig. 19: Global Metagenomics Market, for Whole Genome Sequencing, 2018-2030 (USD Million)
Fig. 20: Global Metagenomics Market, for Others, 2018-2030 (USD Million)
Fig. 21: Global Metagenomics Market: Product Movement Analysis
Fig. 22: Global Metagenomics Market, for Kits & Reagents, 2018-2030 (USD Million)
Fig. 23: Global Metagenomics Market, for Sequencing & Data Analytics Services, 2018-2030 (USD Million)
Fig. 24: Global Metagenomics Market, for Software, 2018-2030 (USD Million)
Fig. 25: Global Metagenomics Market: Application Movement Analysis
Fig. 26: Global Metagenomics Market, for Environmental, 2018-2030 (USD Million)
Fig. 27: Global Metagenomics Market, for Clinical Diagnostics, 2018-2030 (USD Million)
Fig. 28: Global Metagenomics Market, for Drug Discovery, 2018-2030 (USD Million)
Fig. 29: Global Metagenomics Market, for Biotechnology, 2018-2030 (USD Million)
Fig. 30: Global Metagenomics Market, for Food & Nutrition, 2018-2030 (USD Million)
Fig. 31: Global Metagenomics Market, for Others, 2018-2030 (USD Million)
Fig. 32: Global Metagenomics Market: Workflow Movement Analysis
Fig. 33: Global Metagenomics Market, for Pre - sequencing, 2018-2030 (USD Million)
Fig. 34: Global Metagenomics Market, for Sequencing, 2018-2030 (USD Million)
Fig. 35: Global Metagenomics Market, for Data Analysis, 2018-2030 (USD Million)
Fig. 36: Regional Marketplace: Key Takeaways
Fig. 37: Regional Outlook, 2021 & 2030
Fig. 38: Global Metagenomics Market: Region Movement Analysis
Fig. 39: North America Metagenomics Market, 2018-2030 (USD Million)
Fig. 40: U.S. Metagenomics Market, 2018-2030 (USD Million)
Fig. 41: Canada Metagenomics Market, 2018-2030 (USD Million)
Fig. 42: Europe Metagenomics Market, 2018-2030 (USD Million)
Fig. 43: Germany Metagenomics Market, 2018-2030 (USD Million)
Fig. 44: UK Metagenomics Market, 2018-2030 (USD Million)
Fig. 45: France Metagenomics Market, 2018-2030 (USD Million)
Fig. 46: Italy Metagenomics Market, 2018-2030 (USD Million)
Fig. 47: Spain Metagenomics Market, 2018-2030 (USD Million)
Fig. 48: Denmark Metagenomics Market, 2018-2030 (USD Million)
Fig. 49: Norway Metagenomics Market, 2018-2030 (USD Million)
Fig. 50: Sweden Metagenomics Market, 2018-2030 (USD Million)
Fig. 51: Asia Pacific Metagenomics Market, 2018-2030 (USD Million)
Fig. 52: Japan Metagenomics Market, 2018-2030 (USD Million)
Fig. 53: China Metagenomics Market, 2018-2030 (USD Million)
Fig. 54: India Metagenomics Market, 2018-2030 (USD Million)
Fig. 55: Thailand Metagenomics Market, 2018-2030 (USD Million)
Fig. 56: Australia Metagenomics Market, 2018-2030 (USD Million)
Fig. 57: South Korea Metagenomics Market, 2018-2030 (USD Million)
Fig. 58: Latin America Metagenomics Market, 2018-2030 (USD Million)
Fig. 59: Brazil Metagenomics Market, 2018-2030 (USD Million)
Fig. 60: Mexico Metagenomics Market, 2018-2030 (USD Million)
Fig. 61: Argentina Metagenomics Market, 2018-2030 (USD Million)
Fig. 62: Middle East and Africa Metagenomics Market, 2018-2030 (USD Million)
Fig. 63: South Africa Metagenomics Market, 2018-2030 (USD Million)
Fig. 64: Saudi Arabia Metagenomics Market, 2018-2030 (USD Million)
Fig. 65: UAE Metagenomics Market, 2018-2030 (USD Million)
Fig. 66: Kuwait Metagenomics Market, 2018-2030 (USD Million)

Companies Mentioned

  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Bio - Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • Oxford Nanopore Technologies
  • Qiagen
  • Takara Bio, Inc.
  • Novogene Co., Ltd.
  • F. Hoffmann - La Roche Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedJune 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 1.34 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.02 Billion
Compound Annual Growth Rate14.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global Metagenomic Sequencing Market by Product & Service (Analysis & Data Interpretation Solutions, Instruments, Reagents & Consumables), Workflow (Data Processing & Analysis, Sample Processing & Library Preparation, Sequencing), Technology, Application - Forecast 2024-2030 - Product Image

Global Metagenomic Sequencing Market by Product & Service (Analysis & Data Interpretation Solutions, Instruments, Reagents & Consumables), Workflow (Data Processing & Analysis, Sample Processing & Library Preparation, Sequencing), Technology, Application - Forecast 2024-2030

  • Report
  • 191 Pages
  • Global
From
Global Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome), Application (Drug Discovery, Diagnostic, Industrial), and Region - Forecast to 2028 - Product Image

Global Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome), Application (Drug Discovery, Diagnostic, Industrial), and Region - Forecast to 2028

  • Report
  • 257 Pages
  • Global
From
Global Metagenomics Sequencing Market Analysis & Forecast to 2024-2034 - Product Image

Global Metagenomics Sequencing Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Metagenomics Global Market Report 2024 - Product Image

Metagenomics Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Metagenomics Market - Forecasts from 2023 to 2028 - Product Image

Metagenomics Market - Forecasts from 2023 to 2028

  • Report
  • 146 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.